Chapin Davis’s cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock YCBD.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-73,000
Closed -$98.5K 240
2025
Q1
$98.5K Sell
73,000
-7,000
-9% -$8.38K 0.03% 215
2024
Q4
$48K Hold
80,000
0.02% 228
2024
Q3
$48K Hold
80,000
0.02% 230
2024
Q2
$49.6K Hold
80,000
0.02% 224
2024
Q1
$66.2K Hold
80,000
0.02% 225
2023
Q4
$56K Sell
80,000
-8,300
-9% -$7.87K 0.02% 207
2023
Q3
$106K Sell
88,300
-25,300
-22% -$59.8K 0.05% 188
2023
Q2
$358K Sell
113,600
-6,400
-5% -$20.1K 0.17% 136
2023
Q1
$401K Hold
120,000
0.21% 123
2022
Q4
$486K Buy
+120,000
New +$480K 0.28% 95

Chapin Davis's YCBD.PRA Position: Q2 2025 in Review

Chapin Davis sold out of cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock (YCBD.PRA) in Q2 2025, closing a stake of 73,000 shares — an estimated $98.5K sold.

Chapin Davis first reported a position in YCBD.PRA in Q4 2022 and held it in 10 quarters. The position peaked at $486K in Q4 2022. 0 funds tracked by Wall St. Rank hold YCBD.PRA as of Q2 2025.

  • Chapin Davis reported no remaining cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock position as of Q2 2025 after selling out during the quarter.
  • Chapin Davis sold 73,000 cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock shares in Q2 2025, an estimated $98.5K.
  • Chapin Davis first reported a position in cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock in Q4 2022 and held it in 10 quarters.
  • Chapin Davis's cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock position peaked at $486K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock as of Q2 2025.

Based on Chapin Davis's 13F filing for Q2 2025, filed 14 Jul 2025.